Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autologous bone marrow transplantation in solid tumors.

G Spitzer1, W Velasquez, F R Dunphy

  • 1St. Louis University, Missouri.

Current Opinion in Oncology
|April 1, 1992
PubMed
Summary

High-dose chemotherapy with autologous stem cell rescue shows promise for solid tumors like germ cell tumors and neuroblastoma. Early application may overcome drug resistance, improving patient outcomes in challenging cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microcirculation in hypertensive patients.

Biorheology·2014
Same author

Randomized double-blind phase II trial comparing gemcitabine plus LY293111 versus gemcitabine plus placebo in advanced adenocarcinoma of the pancreas.

Cancer journal (Sudbury, Mass.)·2009
Same author

Enhancing drug discovery through in silico screening: strategies to increase true positives retrieval rates.

Current medicinal chemistry·2008
Same author

CAMPATH-1M T-cell depleted BMT for SCID: long-term follow-up of 19 children treated 1987-98 in a single center.

Cytotherapy·2002
Same author

Thalidomide for malignant melanoma.

The New England journal of medicine·2001
Same author

Phase I dose escalation study of topotecan combined with alternating schedules of paclitaxel and carboplatin in advanced solid tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2001

Area of Science:

  • Oncology
  • Hematology
  • Stem Cell Transplantation

Background:

  • Autologous stem cell transplantation is an evolving treatment modality for solid tumors.
  • High-dose chemotherapy regimens are being investigated to improve efficacy.

Purpose of the Study:

  • To review recent studies on autologous bone marrow or peripheral blood transplantation in solid tumors.
  • To evaluate the toxicity and activity of high-dose chemotherapy regimens.

Main Methods:

  • Discussion of recent clinical trials involving high-dose cisplatin or carboplatin combined with etoposide and other agents.
  • Analysis of data from trials in nonseminomatous germ cell tumors, neuroblastoma, ovarian cancer, and brain tumors.

Main Results:

Related Experiment Videos

  • High-dose chemotherapy regimens demonstrate significant antitumor activity in specific patient subgroups.
  • Toxicity profiles of combined chemotherapy agents were assessed.

    • Conclusions:

    • The observed antitumor activities suggest potential for early clinical application of these high-dose strategies.
    • Prompt implementation may be crucial to circumvent the development of prevalent drug resistance.